50 results on '"Hirakawa, Miharu"'
Search Results
2. Randomized controlled trial of a new procedure of radiofrequency ablation using an expandable needle for hepatocellular carcinoma
3. Efficacy of reduction therapy of natural human β‐interferon and ribavirin in elderly patients with chronic hepatitis C, genotype 1b and high viral load
4. Amino Acid Substitution in HCV Core Region and Genetic Variation near the IL28B Gene Affect Viral Dynamics during Telaprevir, Peginterferon and Ribavirin Treatment
5. Amino Acid Substitution in HCV Core/NS5A Region and Genetic Variation Near IL28B Gene Affect Treatment Efficacy to Interferon plus Ribavirin Combination Therapy
6. Amino acid substitutions in hepatitis C virus core region predict hepatocarcinogenesis following eradication of HCV RNA by antiviral therapy
7. Stage progression of small hepatocellular carcinoma after radical therapy: comparisons of radiofrequency ablation and surgery using the Markov model
8. Influence of ITPA polymorphisms on decreases of hemoglobin during treatment with pegylated interferon, ribavirin, and telaprevir
9. Clearance of hepatitis B surface antigen during long-term nucleot(s)ide analogues treatment in chronic hepatitis B
10. Effect of early antiviral agent therapy (NS3 and NS5A inhibitors) in chronic hepatitis C null responders
11. Diabetes Enhances Hepatocarcinogenesis in Noncirrhotic, Interferon-treated Hepatitis C Patients
12. New classification of dynamic computed tomography images predictive of malignant characteristics of hepatocellular carcinoma
13. Administration of interferon for two or more years decreases early stage hepatocellular carcinoma recurrence rate after radical ablation: A retrospective study of hepatitis C virus‐related liver cancer
14. HBcrAg is a predictor of post-treatment recurrence of hepatocellular carcinoma during antiviral therapy
15. Efficacy of switching to entecavir monotherapy in Japanese lamivudine‐pretreated patients
16. Amino acid substitution in hepatitis C virus core region and genetic variation near the interleukin 28B gene predict viral response to telaprevir with peginterferon and ribavirin
17. Virus clearance reduces bone fracture in postmenopausal women with osteoporosis and chronic liver disease caused by hepatitis C virus
18. Amino acid substitutions in the hepatitis C virus core region of genotype 1b affect very early viral dynamics during treatment with telaprevir, peginterferon, and ribavirin
19. Clinical and virological effects of long-term (over 5 years) lamivudine therapy
20. Development of HCC in patients receiving adefovir dipivoxil for lamivudine‐resistant hepatitis B virus mutants
21. Association of HLA-DR14 with the Treatment Response in Japanese Patients with Autoimmune Hepatitis
22. Relationship between SNPs in the IL28B region and amino acid substitutions in HCV core region in Japanese patients with chronic hepatitis C
23. Efficacy and Safety of Combination Therapy of Natural Human Interferon .BETA. and Ribavirin in Chronic Hepatitis C Patients with Genotype 2 and High Virus Load
24. Efficacy and Safety of Combination Therapy of Natural Human Interferon Beta and Ribavirin in Chronic Hepatitis C Patients with Genotype 1b and High Virus Load
25. Extending Combination Therapy with Peginterferon plus Ribavirin for Genotype 2 Chronic Hepatitis C Virological Responders: A Pilot Study of 7 Cases
26. Transcatheter arterial chemotherapy with miriplatin for patients with hepatocellular carcinoma and Child-Pugh B liver cirrhosis
27. Increase of rtA181T mutant strains during entecavir therapy for a patient with chronic hepatitis B virus infection
28. Sustained virological response in a patient with chronic hepatitis C treated by monotherapy with the NS3-4A protease inhibitor telaprevir
29. The efficacy of virological response in treatment-naïve patients with chronic hepatitis C treated by NS3-4A protease inhibitor (telaprevir) , pegylated interferon and ribavirin for 12 weeks
30. Losartan reduces the onset of type 2 diabetes in hypertensive Japanese patients with chronic hepatitis C
31. Predictive factors of advanced recurrence after curative resection of small hepatocellular carcinoma
32. Amino acid substitutions in the hepatitis C virus core region of genotype 1b are the important predictor of severe insulin resistance in patients without cirrhosis and diabetes mellitus
33. Efficacy of platinum analogue for advanced hepatocellular carcinoma unresponsive to transcatheter arterial chemoembolization with epirubicin
34. A matched case‐controlled study of 48 and 72 weeks of peginterferon plus ribavirin combination therapy in patients infected with HCV genotype 1b in Japan: amino acid substitutions in HCV core region as predictor of sustained virological response
35. Low hepatitis B virus core-related antigen is a predictor of absence in post-treatment recurrence of hepatocellular carcinoma during antiviral therapy
36. The Efficacy of Interferon-beta Monotherapy for Elderly Patients with Type C Hepatitis of Genotype 2
37. Virological and Biochemical Features in Elderly HCV Patients with Hepatocellular Carcinoma: Amino Acid Substitutions in HCV Core Region as Predictor of Mortality after First Treatment
38. Association of Amino Acid Substitution Pattern in Core Protein of Hepatitis C Virus Genotype 2a High Viral Load and Virological Response to Interferon-Ribavirin Combination Therapy
39. Combination Therapy of Peginterferon and Ribavirin for Chronic Hepatitis C Patients with Genotype 1b and Low-virus Load
40. Sustained virological response reduces incidence of onset of type 2 diabetes in chronic hepatitis C
41. Efficacy in Patients with Dose Reduction in Combination Therapy of Peginterferon and Ribavirin for Chronic Hepatitis C
42. Hepatitis C virus enhances incidence of idiopathic pulmonary fibrosis
43. Hepatocarcinogenesis Following HCV RNA Eradication by Interferon in Chronic Hepatitis Patients
44. Lipiodol and Dye at the Site of Ablation Decreases during RFA
45. The Efficacy of 24-Week Interferon Monotherapy for Type C Liver Cirrhosis in Japanese Patients with Genotype 1b and Low Virus Load
46. New ablation procedure for a radiofrequency liver tissue coagulation system using an expandable needle
47. Simulation of Electron Cyclotron Resonance in a Microwave Discharge Ion Thruster.
48. Hall Thruster.
49. Particle Simulation of Plasma in Electric Propulsion Thrusters.
50. Numerical simulation of plasma particle behavior in a Hall thruster
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.